https://cnspulse.com/https://cnspulse.com/abstracts/https://cnspulse.com/abstracts/001-novel-targets-and-treatments-for-stimulant-use-disorders-and/https://cnspulse.com/abstracts/002-social-neurobehavioral-phenotypes-for-advancement-of-social/https://cnspulse.com/abstracts/003-feasibility-and-preliminary-efficacy-of-tirzepatide-for-indi/https://cnspulse.com/abstracts/004-accelerated-course-of-intermittent-theta-burst-for-methamphe/https://cnspulse.com/abstracts/005-integrating-cognitive-behavioral-therapy-with-repetitive-tra/https://cnspulse.com/abstracts/006-conducting-clinical-trials-using-combined-treatment-modaliti/https://cnspulse.com/abstracts/007-cognitive-behavioral-therapy-following-esketamine-for-major/https://cnspulse.com/abstracts/008-interim-data-from-a-randomized-placebo-controlled-trial-of-a/https://cnspulse.com/abstracts/009-synergistic-biobehavioral-treatments-to-reduce-depression-an/https://cnspulse.com/abstracts/010-novel-therapeutics-with-entactogenic-effects-a-new-frontier/https://cnspulse.com/abstracts/011-emp-01-r-mdma-as-a-next-generation-entactogen-mechanistic-ra/https://cnspulse.com/abstracts/012-intravenous-ketamine-improves-social-anhedonia-in-patients-w/https://cnspulse.com/abstracts/013-ketamine-s-potential-for-treating-loneliness-in-treatment-re/https://cnspulse.com/abstracts/014-objective-measures-of-empathy-prosocial-learning-and-mood-st/https://cnspulse.com/abstracts/015-targeted-interventions-for-suicide-prevention/https://cnspulse.com/abstracts/016-using-intensive-real-time-monitoring-designs-to-identify-pro/https://cnspulse.com/abstracts/017-changes-in-symptoms-of-suicidal-ideation-and-related-symptom/https://cnspulse.com/abstracts/018-psychosocial-interventions-for-older-adults-with-depression/https://cnspulse.com/abstracts/019-efficacy-and-safety-of-a-single-dose-of-psilocybin-for-chron/https://cnspulse.com/abstracts/020-improving-metabolic-health-in-mental-illness-a-transdiagnost/https://cnspulse.com/abstracts/021-psymetric-2-0-development-refinement-and-external-validation/https://cnspulse.com/abstracts/022-treating-psychotropic-associated-weight-gain-in-individuals/https://cnspulse.com/abstracts/023-ptsd-and-diabetes-a-two-way-street-in-metabolic-and-mental-h/https://cnspulse.com/abstracts/024-pmcid-pmc7170451/https://cnspulse.com/abstracts/025-strategies-to-improve-treatment-effect-detection-in-mdd-tria/https://cnspulse.com/abstracts/026-strategies-to-improve-treatment-effect-detection-in-mdd-tria/https://cnspulse.com/abstracts/027-functional-connectivity-of-the-striatum-as-a-biomarker-of-tr/https://cnspulse.com/abstracts/028-depression-and-disturbances-in-circadian-rhythms-pathways-fo/https://cnspulse.com/abstracts/029-towards-an-international-standardized-model-psychopharmacolo/https://cnspulse.com/abstracts/030-the-ascp-model-psychopharmacology-curriculum-update/https://cnspulse.com/abstracts/031-towards-an-international-standardized-model-psychopharmacolo/https://cnspulse.com/abstracts/032-towards-an-international-standardized-model-psychopharmacolo/https://cnspulse.com/abstracts/033-re104-a-novel-serotonergic-psychedelic-4-oh-dipt-prodrug-for/https://cnspulse.com/abstracts/034-a-new-dawn-for-social-anxiety-treatment-clinical-advancement/https://cnspulse.com/abstracts/035-dt-101-a-novel-alpha-amino-3-hydroxy-5-methyl-4-isoxazole-re/https://cnspulse.com/abstracts/036-seltorexant-adjunctive-to-antidepressants-in-adults-with-maj/https://cnspulse.com/abstracts/037-ketamine-treatment-for-non-motor-symptoms-of-parkinson-s-dis/https://cnspulse.com/abstracts/038-forvisirvat-sp-624-a-first-in-human-sirt6-activator-with-an/https://cnspulse.com/abstracts/039-unlocking-medicines-for-neuropsychiatry-by-enhancing-oral-ab/https://cnspulse.com/abstracts/040-bh-200-nelivaptan-a-vasopressin-v1b-receptor-antagonist-in-g/https://cnspulse.com/abstracts/041-novel-oral-rapid-acting-neuroactive-steroid-for-treatment-of/https://cnspulse.com/abstracts/042-a-randomized-placebo-controlled-trial-of-the-fatty-acid-amid/https://cnspulse.com/abstracts/043-prospective-replication-of-an-eeg-biomarker-for-predicting-c/https://cnspulse.com/abstracts/044-findings-from-the-ascp-presidential-task-force-on-psychotrop/https://cnspulse.com/abstracts/045-underutilized-augmenters-in-polypharmacy-regimens-the-case-f/https://cnspulse.com/abstracts/046-rational-and-irrational-psychopharmacology-combinations/https://cnspulse.com/abstracts/047-when-to-switch-versus-augment-pharmacotherapies/https://cnspulse.com/abstracts/048-mondo-combo-do-combinations-of-antipsychotics-ever-make-any/https://cnspulse.com/abstracts/049-comorbidity-polypharmacy-simultaneous-vs-successive-introduc/https://cnspulse.com/abstracts/050-safety-tolerability-and-drug-drug-interaction-concerns-in-po/https://cnspulse.com/abstracts/051-waking-up-to-excessive-daytime-sleepiness-in-psychiatry-and/https://cnspulse.com/abstracts/052-sleep-assessments-as-predictors-of-health-risk-and-depressio/https://cnspulse.com/abstracts/053-smartwatch-measurements-and-controlled-depression-comparativ/https://cnspulse.com/abstracts/054-pmcid-pmc9008579-sleep-and-its-utility-for-mental-health-and/https://cnspulse.com/abstracts/055-deploying-artificial-intelligence-ai-and-large-language-mode/https://cnspulse.com/abstracts/056-designing-the-next-generation-of-studies-of-psychedelics-for/https://cnspulse.com/abstracts/057-using-neuroimaging-to-elucidate-psychedelic-mechanisms-of-ac/https://cnspulse.com/abstracts/058-long-term-outcomes-from-psilocybin-and-response-to-re-dosing/https://cnspulse.com/abstracts/059-critical-methodological-decisions-in-psychedelic-drug-trials/https://cnspulse.com/abstracts/060-regulatory-plenary-ai-based-tools-in-cns-drug-development-a/https://cnspulse.com/abstracts/061-ascp-lifetime-awardee-talk-and-nasrallah-awardee/https://cnspulse.com/abstracts/062-the-tyranny-of-the-p-value-effect-size-matters/https://cnspulse.com/abstracts/063-a-short-journey-through-a-50-years-of-progress-in-the-treatm/https://cnspulse.com/abstracts/064-clinical-updates-on-neurotherapeutics-disease-state/https://cnspulse.com/abstracts/065-sgas-vs-mood-stabilizers-the-paradigm-shift-in-core-treatmen/https://cnspulse.com/abstracts/066-an-update-on-bipolar-disorder-evidence-challenges-and-soluti/https://cnspulse.com/abstracts/067-the-pharmacologic-treatment-of-schizophrenia-status-report/https://cnspulse.com/abstracts/068-exciting-new-findings-from-clinical-trials-in-the-treatment/https://cnspulse.com/abstracts/069-schizophrenia-polygenic-risk-is-negatively-associated-with-b/https://cnspulse.com/abstracts/070-retrospective-analysis-of-real-world-transition-strategies-f/https://cnspulse.com/abstracts/071-sleep-estimation-from-low-frequency-smartphone-sensors-via-b/https://cnspulse.com/abstracts/072-neural-and-behavioral-evidence-from-reinforcement-learning-c/https://cnspulse.com/abstracts/073-augmenting-dorsolateral-prefrontal-cortex-targeted-tdcs-with/https://cnspulse.com/abstracts/074-mixed-amphetamine-salts-and-lisdexamfetamine-as-adjunctive-t/https://cnspulse.com/abstracts/075-brain-to-brain-movie-neurofeedback-reduces-craving-in-opioid/https://cnspulse.com/abstracts/076-33959050-pmcid-pmc8093505/https://cnspulse.com/abstracts/077-evaluating-hepatic-effects-of-serial-ketamine-infusions-for/https://cnspulse.com/abstracts/078-drug-liking-and-craving-of-intravenous-ketamine-when-prescri/https://cnspulse.com/abstracts/079-combined-ketamine-and-cognitive-behavioral-therapy-leveragin/https://cnspulse.com/abstracts/080-repeated-ketamine-infusions-for-treatment-resistant-bipolar/https://cnspulse.com/abstracts/081-10-1177-20451253231202723-pmid-37771417-pmcid-pmc10524067/https://cnspulse.com/abstracts/082-ampa-receptor-binding-potential-is-reduced-in-the-anterior-c/https://cnspulse.com/abstracts/083-pmid-31959988/https://cnspulse.com/abstracts/084-durability-of-tms-treatment-for-veterans-with-mdd-examined-v/https://cnspulse.com/abstracts/085-is-brain-insulin-action-implicated-in-the-biology-of-depress/https://cnspulse.com/abstracts/086-semaglutide-improves-health-related-quality-of-life-in-major/https://cnspulse.com/abstracts/087-moving-beyond-sleep-the-broader-connection-between-the-orexi/https://cnspulse.com/abstracts/088-incorporating-novel-muscarinic-agents-for-schizophrenia-into/https://cnspulse.com/abstracts/089-6736-25-02365-7-pmid-41763745/https://cnspulse.com/abstracts/090-ai-beyond-evil-robots-ensuring-transformative-means-better/https://cnspulse.com/abstracts/091-update-from-federal-and-other-funding-agencies/https://cnspulse.com/abstracts/092-niaaa-update-focus-on-the-medications-development-program/https://cnspulse.com/abstracts/093-patient-centered-comparative-effectiveness-research/https://cnspulse.com/abstracts/094-advancing-therapeutics-for-substance-use-disorders-through-n/https://cnspulse.com/abstracts/095-pmid-40395395-pmcid-pmc12089859-update-from-defense-health-a/https://cnspulse.com/abstracts/096-updates-from-veteran-health-administration-va-research-initi/https://cnspulse.com/abstracts/097-nimh-update/https://cnspulse.com/abstracts/098-durability-outcomes-in-treatment-resistant-depression/https://cnspulse.com/abstracts/099-transcranial-magnetic-stimulation-durability-of-anti-depress/https://cnspulse.com/abstracts/100-durability-of-vagus-nerve-stimulation-treatment-resistant-de/https://cnspulse.com/abstracts/101-beyond-the-acute-course-exploring-the-durability-of-ketamine/https://cnspulse.com/abstracts/102-15-pmid-40834563/https://cnspulse.com/abstracts/103-40319349-pmcid-pmc12143125-how-durable-are-acute-effects-of/https://cnspulse.com/abstracts/104-evolving-understandings-of-psychedelics-in-clinical-research/https://cnspulse.com/abstracts/105-understanding-psilocybin-administration-dose-participant-cha/https://cnspulse.com/abstracts/106-recruiting-retaining-and-tailoring-psychedelic-clinical-tria/https://cnspulse.com/abstracts/107-evaluating-the-clinical-utility-of-psilocybin-therapy-versus/https://cnspulse.com/abstracts/108-building-collaborative-capacity-in-early-career-psychopharma/https://cnspulse.com/abstracts/109-the-evolving-nature-of-academic-industry-partnerships/https://cnspulse.com/abstracts/110-pmcid-pmc11000613-take-aways-from-my-experience-starting-out/https://cnspulse.com/abstracts/111-10-1056-nejm1994052633021131530-1533-why-do-we-need-team-sci/https://cnspulse.com/abstracts/112-39171416-pmcid-pmc11652247/https://cnspulse.com/abstracts/113-03008-5-pmid-39054336-pmcid-pmc11272929-development-of-esket/https://cnspulse.com/abstracts/114-are-early-career-clinical-researchers-in-psychiatry-an-endan/https://cnspulse.com/abstracts/115-the-young-investigator-as-a-pluripotent-stem-cell-the-role-o/https://cnspulse.com/abstracts/116-communication-and-conflict-management-practical-tools-for-ef/https://cnspulse.com/abstracts/117-advances-in-depression-research-a-tribute-to-nolan-williams/https://cnspulse.com/abstracts/118-understanding-and-harnessing-the-opioid-effects-of-ketamine/https://cnspulse.com/abstracts/119-non-invasive-amygdala-neuromodulation-in-humans-with-focused/https://cnspulse.com/abstracts/120-clinical-and-neural-outcomes-of-magnesium-ibogaine-for-traum/https://cnspulse.com/abstracts/121-photobiomodulation-with-near-infrared-light-a-novel-treatmen/https://cnspulse.com/abstracts/122-dose-dependent-effects-of-transcranial-photobiomodulation-on/https://cnspulse.com/abstracts/123-6-pmid-39370461-transcranial-photobiomodulation-for-alzheime/https://cnspulse.com/abstracts/124-transcranial-infrared-laser-stimulation-improves-cognitive-p/https://cnspulse.com/abstracts/125-uncovering-mechanisms-of-photobiomodulation-behind-clinical/https://cnspulse.com/abstracts/126-lessons-from-transforming-the-psychiatric-healthcare-system/https://cnspulse.com/abstracts/127-alignment-for-progress-a-movement-to-bring-change/https://cnspulse.com/abstracts/128-one-expert-by-experience-journey/https://cnspulse.com/abstracts/129-challenges-of-building-a-learning-health-system-for-early-ps/https://cnspulse.com/abstracts/130-transforming-the-healthcare-system-with-the-bipolar-action-n/https://cnspulse.com/abstracts/131-developing-treatments-for-the-non-motor-symptoms-of-parkinso/https://cnspulse.com/abstracts/132-ab-300-a-novel-5-ht2a-2c-agonist-reverses-motivational-defic/https://cnspulse.com/abstracts/133-psilocybin-therapy-for-depression-in-parkinson-s-disease/https://cnspulse.com/abstracts/134-targeting-synaptic-loss-in-parkinson-s-disease-depression-wi/https://cnspulse.com/abstracts/135-artificial-intelligence-understanding-the-present-and-antici/https://cnspulse.com/abstracts/136-using-artificial-intelligence-and-social-media-data-for-popu/https://cnspulse.com/abstracts/137-assessing-ai-for-clinical-care-and-research/https://cnspulse.com/abstracts/138-bridging-ai-innovation-and-clinical-trial-data-in-psychiatry/https://cnspulse.com/abstracts/139-what-to-know-about-ketamine-safety-patient-monitoring-neurot/https://cnspulse.com/abstracts/140-racemic-ketamine-side-effects-adverse-reactions-and-monitori/https://cnspulse.com/abstracts/141-ketamine-for-depression-but-at-what-cost-evidence-for-neurot/https://cnspulse.com/abstracts/142-use-of-ketamine-for-depression-in-special-populations/https://cnspulse.com/abstracts/143-the-discovery-and-clinical-development-of-2r-6r-hydroxynorke/https://cnspulse.com/abstracts/144-from-ketamine-metabolite-to-candidate-therapeutic-preclinica/https://cnspulse.com/abstracts/145-preclinical-development-of-2r-6r-hydroxynorketamine-for-huma/https://cnspulse.com/abstracts/146-clinical-development-of-2r-6r-hydroxynorketamine-ongoing-tri/https://cnspulse.com/abstracts/147-evaluation-of-the-2r-6r-hydroxynorketamine-as-a-potential-cl/https://cnspulse.com/abstracts/148-new-and-anticipated-interventions-for-perinatal-depression/https://cnspulse.com/abstracts/149-pathophysiological-mechanisms-of-perinatal-depression/https://cnspulse.com/abstracts/150-epigenetic-biomarkers-in-postpartum-depression-and-postpartu/https://cnspulse.com/abstracts/151-approved-and-potential-treatments-for-ppd/https://cnspulse.com/abstracts/152-addiction-and-neuromodulation-in-pregnancy/https://cnspulse.com/abstracts/153-the-future-dsm-designing-a-scientific-inclusive-and-practica/https://cnspulse.com/abstracts/154-the-future-dsm-designing-a-scientific-inclusive-and-practica/https://cnspulse.com/abstracts/155-structure-and-dimensions-subcommittee/https://cnspulse.com/abstracts/156-the-dsm-subcommittee-on-candidate-biomarkers-and-biological/https://cnspulse.com/abstracts/157-regulatory-challenges-ask-the-experts/https://cnspulse.com/abstracts/158-w1-the-phase-2-3-gain-trial-of-the-first-generation-p-gingiv/https://cnspulse.com/abstracts/159-w2-galantamine-memantine-combination-regulating-the-kynureni/https://cnspulse.com/abstracts/160-w3-dynamic-causal-modeling-of-triple-network-connectivity-va/https://cnspulse.com/abstracts/161-w4-a-review-of-evidence-and-an-algorithm-for-use-of-psychoph/https://cnspulse.com/abstracts/162-w5-evidence-from-randomized-controlled-trials-in-substance-u/https://cnspulse.com/abstracts/163-w6-changes-in-smoking-related-outcomes-with-tirzepatide-in-i/https://cnspulse.com/abstracts/164-w7-changes-in-depressive-symptoms-with-tirzepatide-in-indivi/https://cnspulse.com/abstracts/165-w8-safety-and-tolerability-of-32-week-long-treatment-with-ti/https://cnspulse.com/abstracts/166-w9-first-dose-treatment-effects-with-injectable-weekly-and-m/https://cnspulse.com/abstracts/167-w10-a-new-dawn-for-social-anxiety-treatment-clinical-advance/https://cnspulse.com/abstracts/168-w11-treatment-patterns-among-incident-and-persistent-patient/https://cnspulse.com/abstracts/169-w12-the-impact-of-comorbid-psychiatric-disorders-on-miscondu/https://cnspulse.com/abstracts/170-w13-the-neurochemical-and-anxiolytic-like-effects-of-centana/https://cnspulse.com/abstracts/171-w14-growing-trend-of-stimulant-use-in-young-patients-misdiag/https://cnspulse.com/abstracts/172-w15-emotional-dysregulation-symptom-outcomes-in-adults-with/https://cnspulse.com/abstracts/173-w16-the-persistence-of-neuroepithelial-progenitors-in-neocor/https://cnspulse.com/abstracts/174-w17-long-term-safety-and-tolerability-of-cariprazine-in-pedi/https://cnspulse.com/abstracts/175-w18-e2086-a-selective-orexin-receptor-2-agonist-study-for-pr/https://cnspulse.com/abstracts/176-w19-the-complex-multi-system-symptom-inventory-comss-a-new-i/https://cnspulse.com/abstracts/177-w20-static-and-dynamic-disruptions-of-salience-network-flexi/https://cnspulse.com/abstracts/178-w21-successful-early-treatment-of-anti-n-methyl-d-aspartate/https://cnspulse.com/abstracts/179-w22-gh001-efficacy-is-independent-of-prior-antidepressant-tr/https://cnspulse.com/abstracts/180-w23-examining-the-impact-of-patient-centered-approaches-on-t/https://cnspulse.com/abstracts/181-w24-seltorexant-versus-quetiapine-extended-release-as-adjunc/https://cnspulse.com/abstracts/182-w25-benefits-of-adjunctive-vagus-nerve-stimulation-in-diffic/https://cnspulse.com/abstracts/183-w26-pooled-individual-patient-data-analysis-of-three-phase-2/https://cnspulse.com/abstracts/184-w27-genetically-defined-subgroup-analysis-reveals-differenti/https://cnspulse.com/abstracts/185-w28-characteristics-of-depression-episodes-to-inform-real-wo/https://cnspulse.com/abstracts/186-w29-longitudinal-profiling-of-treatment-trajectories-in-ssri/https://cnspulse.com/abstracts/187-w30-dimensions-of-psychedelic-experience-predicting-antidepr/https://cnspulse.com/abstracts/188-w31-anxious-depression-as-predictor-of-clinical-outcomes-in/https://cnspulse.com/abstracts/189-w32-neuroactive-steroid-changes-pre-and-post-ketamine-during/https://cnspulse.com/abstracts/190-w33-association-of-major-depressive-disorder-with-insomnia-s/https://cnspulse.com/abstracts/191-w34-esmethadone-rel-1017-in-patients-with-antidepressant-tac/https://cnspulse.com/abstracts/192-w35-preclinical-behavioral-and-pharmacological-characteristi/https://cnspulse.com/abstracts/193-w36-metabolic-profile-of-adjunctive-lumateperone-42-mg-in-ma/https://cnspulse.com/abstracts/194-w37-lumateperone-42-mg-in-major-depressive-disorder-demograp/https://cnspulse.com/abstracts/195-w38-efficacy-of-lumateperone-42-mg-for-the-treatment-of-majo/https://cnspulse.com/abstracts/196-w39-psychopharmacology-of-enx-104-a-potent-dopamine-da-d2-d3/https://cnspulse.com/abstracts/197-w40-impact-of-gh001-on-depressive-symptoms-anxiety-and-quali/https://cnspulse.com/abstracts/198-w41-rapid-and-sustained-improvement-in-anhedonia-following-i/https://cnspulse.com/abstracts/199-w42-effects-of-dextromethorphan-bupropion-45mg-105mg-in-part/https://cnspulse.com/abstracts/200-w43-hj-006-a-non-hallucinogenic-synaptogenic-compound-with-r/https://cnspulse.com/abstracts/201-w45-psychomotor-disturbance-as-a-predictor-of-treatment-resp/https://cnspulse.com/abstracts/202-w46-the-monotherapy-antidepressant-pipeline-problem-only-8-a/https://cnspulse.com/abstracts/203-w47-early-response-to-psilocybin-in-adults-with-treatment-re/https://cnspulse.com/abstracts/204-w48-early-motivational-and-hedonic-responses-to-antidepressa/https://cnspulse.com/abstracts/205-w49-real-world-evidence-of-the-clinical-and-preference-impac/https://cnspulse.com/abstracts/206-w50-anxiolytic-effects-of-dextromethorphan-bupropion-45mg-10/https://cnspulse.com/abstracts/207-w51-multimodal-identification-of-neurobiological-subtypes-as/https://cnspulse.com/abstracts/208-w52-orexin-2-receptor-agonists-as-a-potential-therapeutic-ap/https://cnspulse.com/abstracts/209-w53-a-novel-disease-modifying-strategy-for-narcolepsy-type-1/https://cnspulse.com/abstracts/210-w54-targeted-eligibility-review-can-decrease-the-number-of-i/https://cnspulse.com/abstracts/211-w55-impact-ext-evaluating-the-durability-and-redosing-of-tsn/https://cnspulse.com/abstracts/212-w56-safety-pharmacokinetics-and-pharmacodynamics-of-msd-001/https://cnspulse.com/abstracts/213-w57-blinding-integrity-in-psychedelic-randomized-controlled/https://cnspulse.com/abstracts/214-w58-unlocking-medicines-for-neuropsychiatry-by-enhancing-ora/https://cnspulse.com/abstracts/215-w59-a-randomized-placebo-controlled-trial-of-the-fatty-acid/https://cnspulse.com/abstracts/216-w60-efficacy-safety-and-tolerability-of-lysergic-acid-diethy/https://cnspulse.com/abstracts/217-crd420251063539/https://cnspulse.com/abstracts/218-w61-beyond-mood-broader-psychological-benefits-of-iv-ketamin/https://cnspulse.com/abstracts/219-w62-the-complex-diagnostic-profile-of-psychiatric-outpatient/https://cnspulse.com/abstracts/220-w63-sodium-glucose-cotransporter-2-inhibitors-reduce-suicida/https://cnspulse.com/abstracts/221-w64-preclinical-efficacy-of-concomitant-administration-of-no/https://cnspulse.com/abstracts/222-w65-the-neurobiological-effects-of-psilocybin-in-treatment-r/https://cnspulse.com/abstracts/223-w66-effect-of-cariprazine-treatment-on-sleep-and-mood-sympto/https://cnspulse.com/abstracts/224-w67-an-open-label-two-arm-study-of-ketamine-s-effects-on-flu/https://cnspulse.com/abstracts/225-w68-tirzepatide-precipitating-acute-lithium-toxicity-in-stab/https://cnspulse.com/abstracts/226-w69-effects-of-cariprazine-on-symptoms-of-anxiety-a-pooled-p/https://cnspulse.com/abstracts/227-w70-real-world-impact-on-anxiety-symptoms-of-cariprazine-as/https://cnspulse.com/abstracts/228-w71-antipsychotic-switching-among-patients-with-bipolar-i-de/https://cnspulse.com/abstracts/229-w72-comparative-efficacy-of-bupropion-vs-selective-serotonin/https://cnspulse.com/abstracts/230-w73-effect-of-psychedelic-therapies-on-sleep-in-psychiatric/https://cnspulse.com/abstracts/231-w74-impact-of-seltorexant-on-cognitive-performance-of-adults/https://cnspulse.com/abstracts/232-w75-intermittent-white-light-at-60-hz-as-a-potential-neurost/https://cnspulse.com/abstracts/233-nct07111390-w76-safety-and-efficacy-of-full-and-half-dose-ne/https://cnspulse.com/abstracts/234-w77-real-world-evidence-from-legal-psilocybin-assisted-servi/https://cnspulse.com/abstracts/235-w78-protocol-for-real-world-safety-and-effectiveness-study-o/https://cnspulse.com/abstracts/236-w79-real-world-experience-and-impact-of-fatigue-in-narcoleps/https://cnspulse.com/abstracts/237-w80-activation-of-1r-and-5-ht2a-pathways-modulates-neuroinfl/https://cnspulse.com/abstracts/238-w81-examining-the-impact-of-trauma-on-ketamine-s-efficacy-in/https://cnspulse.com/abstracts/239-w82-real-world-persistence-on-olanzapine-samidorphan-versus/https://cnspulse.com/abstracts/240-w83-using-artificial-intelligence-machine-learning-and-real/https://cnspulse.com/abstracts/241-w84-endocrine-biomarkers-of-suicide-risk-in-schizophrenia/https://cnspulse.com/abstracts/242-w85-clozapine-s-antagonism-is-robust-against-known-drd2-muta/https://cnspulse.com/abstracts/243-w86-impact-of-negative-symptoms-on-healthcare-resource-utili/https://cnspulse.com/abstracts/244-95-ci-0-99-1-39-p-0-06/https://cnspulse.com/abstracts/245-w87-onset-duration-and-incidence-of-adverse-events-by-dose-a/https://cnspulse.com/abstracts/246-w88-suvn-l1101142-a-muscarinic-m4-positive-allosteric-modula/https://cnspulse.com/abstracts/247-w89-occurrence-of-urinary-retention-related-adverse-events-w/https://cnspulse.com/abstracts/248-w90-olanzapine-and-samidorphan-in-adults-with-schizophrenia/https://cnspulse.com/abstracts/249-w91-longitudinal-trends-in-antipsychotic-polytherapy-and-ass/https://cnspulse.com/abstracts/250-w92-efficacy-and-safety-of-xanomeline-and-trospium-chloride/https://cnspulse.com/abstracts/251-w93-real-world-impact-of-olanzapine-and-samidorphan-on-rates/https://cnspulse.com/abstracts/252-w94-translational-evidence-for-dopaminergic-alteration-of-ba/https://cnspulse.com/abstracts/253-w95-memantine-for-the-treatment-of-primary-negative-symptoms/https://cnspulse.com/abstracts/254-w97-risk-of-suicide-attempt-in-newly-diagnosed-adhd-with-and/https://cnspulse.com/abstracts/255-w98-novel-oral-rapid-acting-neuroactive-steroid-for-treatmen/https://cnspulse.com/abstracts/256-w99-acute-treatment-of-postpartum-psychosis-an-update-from-t/https://cnspulse.com/abstracts/257-w100-re104-a-novel-serotonergic-psychedelic-4-oh-dipt-prodru/https://cnspulse.com/abstracts/258-w101-use-of-long-acting-injectable-antipsychotics-in-forensi/https://cnspulse.com/abstracts/259-w102-suicide-risk-of-third-generation-antipsychotics-in-pers/https://cnspulse.com/abstracts/260-w103-aripiprazole-once-monthly-for-patients-living-with-schi/https://cnspulse.com/abstracts/261-w105-machine-learning-detection-of-arousals-from-at-home-sle/https://cnspulse.com/abstracts/262-w106-higher-polygenic-risk-for-mitochondrial-dysfunction-is/https://cnspulse.com/abstracts/263-w107-choroid-plexus-volume-as-a-biomarker-of-ketamine-relate/https://cnspulse.com/abstracts/264-w108-challenges-and-strategies-for-training-and-retaining-th/https://cnspulse.com/abstracts/265-w109-applying-scientific-and-operational-insights-from-prior/https://cnspulse.com/abstracts/266-w110-initial-psychometric-properties-of-the-anhedonia-interv/https://cnspulse.com/abstracts/267-w111-a-first-in-human-study-to-evaluate-safety-pharmacokinet/https://cnspulse.com/abstracts/268-w112-demographic-and-clinical-characteristics-of-participant/https://cnspulse.com/abstracts/269-w113-closing-the-care-gap-embedding-ptsd-screening-in-primar/https://cnspulse.com/abstracts/270-w114-durability-of-efficacy-and-safety-of-comp360-psilocybin/https://cnspulse.com/abstracts/271-w115-elunetirom-a-first-in-class-brain-targeting-antidepress/https://cnspulse.com/abstracts/272-w116-lysergide-tartrate-lsd-dt120-safety-profile-from-phase/https://cnspulse.com/abstracts/273-w117-rational-deprescribing-ascp-expert-consensus-for-mood-d/https://cnspulse.com/abstracts/274-w118-the-association-between-ketamine-and-esketamine-and-uro/https://cnspulse.com/abstracts/275-w119-efficacy-and-safety-of-xanomeline-trospium-chloride-dur/https://cnspulse.com/abstracts/276-w120-silence-is-golden-speech-production-during-psilocybin-a/https://cnspulse.com/abstracts/277-w121-a-novel-interactive-digital-learning-tool-discover-td-f/https://cnspulse.com/abstracts/278-w122-impact-of-a-three-part-online-educational-webinar-serie/https://cnspulse.com/abstracts/279-w123-identifying-and-predicting-symptom-trajectories-in-a-bl/https://cnspulse.com/abstracts/280-w124-cognitive-impairment-in-major-depressive-disorder-a-pat/https://cnspulse.com/abstracts/281-w125-evaluation-of-vedai-across-clinical-psychiatry-a-blinde/https://cnspulse.com/abstracts/282-w126-pharmacological-validation-of-neurokit-as-a-portable-se/https://cnspulse.com/abstracts/283-w127-modeling-continuous-time-network-dynamics-of-passive-se/https://cnspulse.com/abstracts/284-t1-ketamine-treatment-for-non-motor-symptoms-of-parkinson-s/https://cnspulse.com/abstracts/285-t2-effects-of-itraconazole-and-carbamazepine-on-the-pharmaco/https://cnspulse.com/abstracts/286-t3-correlation-of-plasma-p-tau217-and-csf-p-tau181-with-clin/https://cnspulse.com/abstracts/287-t4-assessing-community-pharmacist-preparedness-to-implement/https://cnspulse.com/abstracts/288-t5-understanding-kratom-s-effects-and-abuse-potential-design/https://cnspulse.com/abstracts/289-t6-menstrual-phase-driven-frontal-white-matter-microstructur/https://cnspulse.com/abstracts/290-t7-semaglutide-for-the-treatment-of-opioid-use-disorder-inte/https://cnspulse.com/abstracts/291-t8-office-based-treatment-retention-among-patients-with-opio/https://cnspulse.com/abstracts/292-t9-real-world-utilization-trends-of-weekly-and-monthly-injec/https://cnspulse.com/abstracts/293-t10-the-pharmacokinetic-properties-and-target-engagement-eff/https://cnspulse.com/abstracts/294-t11-efficacy-and-safety-of-ulotaront-in-adults-with-generali/https://cnspulse.com/abstracts/295-t12-mazindol-ir-sr-a-50-year-legacy-repositioned-as-a-first/https://cnspulse.com/abstracts/296-t13-comprehensive-multitarget-strategy-for-type-1-diabetes-a/https://cnspulse.com/abstracts/297-t14-investigating-the-safety-efficacy-and-tolerability-of-ad/https://cnspulse.com/abstracts/298-t15-asrs-outcomes-across-core-and-expanded-symptom-domains-a/https://cnspulse.com/abstracts/299-t16-executive-function-symptom-outcomes-in-adults-with-adhd/https://cnspulse.com/abstracts/300-t17-pathophysiological-analysis-of-autism-spectrum-disorder/https://cnspulse.com/abstracts/301-t18-psychotropic-prescribing-trends-within-the-texas-juvenil/https://cnspulse.com/abstracts/302-t19-sleep-architecture-in-participants-with-insomnia-disorde/https://cnspulse.com/abstracts/303-t20-psilocybin-assisted-psychotherapy-for-cluster-b-personal/https://cnspulse.com/abstracts/304-t21-pharmacotherapies-for-co-occurring-stimulant-use-disorde/https://cnspulse.com/abstracts/305-t22-effects-of-glucagon-like-peptide-1-receptor-agonists-glp/https://cnspulse.com/abstracts/306-t23-prevalence-of-psychotropic-medication-use-among-patients/https://cnspulse.com/abstracts/307-t24-prospective-replication-of-an-eeg-biomarker-for-predicti/https://cnspulse.com/abstracts/308-t25-bh-200-nelivaptan-a-vasopressin-v1b-receptor-antagonist/https://cnspulse.com/abstracts/309-t26-a-phase-2-clinical-trial-exploring-efficacy-and-safety-o/https://cnspulse.com/abstracts/310-t27-forvisirvat-sp-624-a-first-in-human-sirt6-activator-with/https://cnspulse.com/abstracts/311-t28-effect-of-ketamine-on-individual-symptoms-of-depression/https://cnspulse.com/abstracts/312-t29-effects-of-solriamfetol-on-neuropsychological-outcomes-i/https://cnspulse.com/abstracts/313-t30-metabolic-profiles-of-participants-with-major-depressive/https://cnspulse.com/abstracts/314-t31-decrease-in-negative-mood-and-increase-in-positive-mood/https://cnspulse.com/abstracts/315-t32-use-of-a-prospective-lead-in-study-to-enhance-eligibilit/https://cnspulse.com/abstracts/316-t33-metabolic-burden-inflammation-and-esketamine-efficacy-in/https://cnspulse.com/abstracts/317-t34-real-world-clinical-outcomes-of-patients-switching-to-tr/https://cnspulse.com/abstracts/318-t35-efficacy-and-safety-of-esmethadone-rel-1017-in-patients/https://cnspulse.com/abstracts/319-t36-lumateperone-versus-other-adjunctive-atypical-antipsycho/https://cnspulse.com/abstracts/320-t37-a-phase-ib-study-evaluating-safety-preliminary-efficacy/https://cnspulse.com/abstracts/321-t38-real-world-effectiveness-of-intravenous-ketamine-on-depr/https://cnspulse.com/abstracts/322-t39-evaluating-the-association-between-antidepressant-effica/https://cnspulse.com/abstracts/323-t40-adjunctive-lumateperone-42-mg-treatment-in-major-depress/https://cnspulse.com/abstracts/324-t41-first-onset-and-duration-of-treatment-emergent-adverse-e/https://cnspulse.com/abstracts/325-t42-remission-with-lumateperone-42-mg-adjunctive-to-antidepr/https://cnspulse.com/abstracts/326-t43-peripheral-biomarker-reliability-in-major-depressive-dis/https://cnspulse.com/abstracts/327-t44-evaluating-the-abuse-liability-of-ketamine-in-the-treatm/https://cnspulse.com/abstracts/328-t45-patterns-of-real-world-antipsychotic-switching-after-ini/https://cnspulse.com/abstracts/329-t46-costs-associated-with-adjunctive-atypical-antipsychotic/https://cnspulse.com/abstracts/330-t47-preclinical-evaluation-of-ropanicant-a-nicotinic-acetylc/https://cnspulse.com/abstracts/331-t48-ropanicant-suvn-911-an-4-2-nachr-antagonist-a-phase-2b-r/https://cnspulse.com/abstracts/332-t49-concurrent-oral-antidepressant-use-and-clinical-outcomes/https://cnspulse.com/abstracts/333-t50-psilocybin-treatment-for-chronic-neuropathic-pain-and-de/https://cnspulse.com/abstracts/334-t51-convergent-validity-and-treatment-responsiveness-of-the/https://cnspulse.com/abstracts/335-t52-an-investigation-of-the-putative-antidepressant-mechanis/https://cnspulse.com/abstracts/336-t53-a-language-derived-affective-sentiment-dimension-of-keta/https://cnspulse.com/abstracts/337-t54-interpreting-psychiatric-digital-phenotyping-data-with-l/https://cnspulse.com/abstracts/338-t55-a-simulation-based-framework-for-characterizing-risk-in/https://cnspulse.com/abstracts/339-t56-ai-enabled-patient-derived-neuronal-models-for-mechanism/https://cnspulse.com/abstracts/340-t57-sustained-pharmacodynamic-effects-of-esketamine-on-corti/https://cnspulse.com/abstracts/341-t58-alto-207-a-fixed-dose-combination-of-pramipexole-and-ond/https://cnspulse.com/abstracts/342-t59-effects-of-alixorexton-on-patient-reported-disease-sever/https://cnspulse.com/abstracts/343-t60-safety-and-efficacy-results-from-the-phase-2-vibrance-1/https://cnspulse.com/abstracts/344-t61-the-use-of-magnetoencephalography-meg-in-a-first-in-huma/https://cnspulse.com/abstracts/345-t62-cross-trial-identification-of-a-predictive-enrichment-su/https://cnspulse.com/abstracts/346-t63-prediction-of-human-pharmacokinetic-profiles-of-glyph-pl/https://cnspulse.com/abstracts/347-t64-evaluating-potential-abuse-related-adverse-events-in-cli/https://cnspulse.com/abstracts/348-t65-dt-101-a-novel-alpha-amino-3-hydroxy-5-methyl-4-isoxazol/https://cnspulse.com/abstracts/349-t66-using-artificial-intelligence-machine-learning-and-real/https://cnspulse.com/abstracts/350-t67-do-nondsm-criteria-enhance-the-validity-of-the-dsm-5-mix/https://cnspulse.com/abstracts/351-t68-multifocal-negative-affect-the-prevalence-and-clinical-p/https://cnspulse.com/abstracts/352-t69-the-mcintyre-and-rosenblat-rapid-response-scale-marrrs-a/https://cnspulse.com/abstracts/353-t70-changes-in-sleep-patterns-with-psilocybin-assisted-psych/https://cnspulse.com/abstracts/354-t71-psilocybin-for-anhedonia-a-systematic-review-of-clinical/https://cnspulse.com/abstracts/355-t72-don-t-let-ai-make-you-moody-assessing-racial-bias-in-lar/https://cnspulse.com/abstracts/356-t73-evaluating-the-potential-risk-of-ketamine-induced-hepato/https://cnspulse.com/abstracts/357-t74-cognitive-outcomes-following-serial-ketamine-infusions-i/https://cnspulse.com/abstracts/358-t75-a-pilot-study-of-sodium-glucose-cotransporter-2-sglt2-in/https://cnspulse.com/abstracts/359-t76-efficacy-of-cariprazine-for-anhedonia-symptoms-a-pooled/https://cnspulse.com/abstracts/360-t77-differential-effects-of-transcranial-photobiomodulation/https://cnspulse.com/abstracts/361-t78-comparison-of-the-efficacy-of-neuromodulation-therapies/https://cnspulse.com/abstracts/362-t79-harmonizing-adverse-event-criteria-to-improve-cns-relate/https://cnspulse.com/abstracts/363-t80-real-world-experience-and-impact-of-cognitive-impairment/https://cnspulse.com/abstracts/364-t81-a-head-to-head-assessment-of-vmat2-target-occupancy-of-o/https://cnspulse.com/abstracts/365-t82-opioid-use-in-patients-with-fibromyalgia-a-retrospective/https://cnspulse.com/abstracts/366-t83-complications-of-an-abrupt-switch-from-a-full-antagonist/https://cnspulse.com/abstracts/367-t84-impact-2-a-phase-2-randomized-dose-response-trial-of-tsn/https://cnspulse.com/abstracts/368-t85-symptoms-of-post-traumatic-stress-disorder-in-individual/https://cnspulse.com/abstracts/369-t86-a-systematic-literature-review-on-anti-psychotic-utiliza/https://cnspulse.com/abstracts/370-t87-dt120-lysergide-lsd-assessing-the-potential-risk-of-card/https://cnspulse.com/abstracts/371-t88-real-world-treatment-patterns-in-manic-mixed-bipolar-i-d/https://cnspulse.com/abstracts/372-t89-ml-007c-ma-a-novel-investigational-m1-m4-muscarinic-agon/https://cnspulse.com/abstracts/373-t90-efficacy-of-xanomeline-and-trospium-chloride-across-symp/https://cnspulse.com/abstracts/374-t91-the-metabolic-cognitive-pathway-in-schizophrenia-examini/https://cnspulse.com/abstracts/375-t92-inpatient-initiation-of-the-long-acting-injectable-antip/https://cnspulse.com/abstracts/376-t93-safety-and-efficacy-of-aripiprazole-lauroxil-in-an-outpa/https://cnspulse.com/abstracts/377-t94-lb-102-for-acute-schizophrenia-in-adults-results-from-th/https://cnspulse.com/abstracts/378-t95-role-of-glp-1-receptor-agonists-in-managing-antipsychoti/https://cnspulse.com/abstracts/379-t96-real-world-use-of-xanomeline-and-trospium-chloride-in-sc/https://cnspulse.com/abstracts/380-t97-real-world-comparison-of-olanzapine-samidorphan-vs-olanz/https://cnspulse.com/abstracts/381-t98-real-world-outcomes-and-psychological-predictors-in-an-8/https://cnspulse.com/abstracts/382-t99-resting-state-eeg-signatures-of-suicidal-ideation-severi/https://cnspulse.com/abstracts/383-t100-attitudes-toward-artificial-intelligence-clinical-decis/https://cnspulse.com/abstracts/384-t101-the-national-pregnancy-registry-for-psychiatric-medicat/https://cnspulse.com/abstracts/385-t102-pregnancy-outcomes-after-first-trimester-exposure-to-vo/https://cnspulse.com/abstracts/386-t103-risk-of-major-malformations-following-first-trimester-e/https://cnspulse.com/abstracts/387-t104-artificial-intelligence-assisted-participant-recruitmen/https://cnspulse.com/abstracts/388-t105-active-and-passive-digital-phenotyping-to-measure-outco/https://cnspulse.com/abstracts/389-t106-exosomes-and-a-novel-mitochondrial-mechanism-of-epigene/https://cnspulse.com/abstracts/390-t107-perspectives-of-nurse-practitioners-and-physician-assoc/https://cnspulse.com/abstracts/391-t108-a-novel-brain-penetrant-kat-ii-inhibitor-kyn-5356-reduc/https://cnspulse.com/abstracts/392-t109-racial-differences-in-antidepressant-initiation-and-out/https://cnspulse.com/abstracts/393-t110-efficacy-and-safety-of-comp360-psilocybin-for-treatment/https://cnspulse.com/abstracts/394-t111-esketamine-nasal-spray-for-relapse-prevention-in-patien/https://cnspulse.com/abstracts/395-t112-validation-of-the-neurokit-platform-for-central-nervous/https://cnspulse.com/abstracts/396-t113-connectedness-as-a-mechanism-of-change-in-psilocybin-as/https://cnspulse.com/abstracts/397-t114-next-generation-pharmacotherapies-for-mood-and-anxiety/https://cnspulse.com/abstracts/398-t115-open-label-randomized-study-to-assess-safety-and-effica/https://cnspulse.com/abstracts/399-t116-from-nightmares-to-depression-age-stratified-neuropsych/https://cnspulse.com/abstracts/400-t117-improvement-of-predominant-negative-symptoms-in-patient/https://cnspulse.com/abstracts/401-t118-efficacy-of-sublingual-dexmedetomidine-in-the-home-sett/https://cnspulse.com/abstracts/402-t119-long-term-metabolic-and-cardiovascular-safety-and-toler/https://cnspulse.com/abstracts/403-t120-schizophrenia-related-hospitalization-history-before-lo/https://cnspulse.com/abstracts/404-t121-outcomes-in-depression-symptomatology-with-high-and-low/https://cnspulse.com/abstracts/405-t122-real-world-safety-and-effectiveness-of-lurasidone-in-ch/https://cnspulse.com/abstracts/406-t123-real-world-evidence-of-clinical-treatment-response-foll/https://cnspulse.com/abstracts/407-t124-multiclass-environmental-toxicants-found-in-cerebrospin/https://cnspulse.com/abstracts/408-t125-continuous-multimodal-passive-monitoring-of-depressive/https://cnspulse.com/abstracts/409-t126-comparable-symptom-improvement-with-electroconvulsive-t/https://cnspulse.com/abstracts/index/https://cnspulse.com/authors/https://cnspulse.com/authors/abdul-khan/https://cnspulse.com/authors/adam-fijtman/https://cnspulse.com/authors/adele-viguera/https://cnspulse.com/authors/afrah-mohammad/https://cnspulse.com/authors/aishwarya-prasad/https://cnspulse.com/authors/alan-schatzberg/https://cnspulse.com/authors/alana-king/https://cnspulse.com/authors/alexander-bystritsky/https://cnspulse.com/authors/alexander-mcgirr/https://cnspulse.com/authors/alexandra-gordon/https://cnspulse.com/authors/alexandria-greifenberger/https://cnspulse.com/authors/allison-mandell/https://cnspulse.com/authors/amanda-jones/https://cnspulse.com/authors/amrita-ghose/https://cnspulse.com/authors/amy-wegener/https://cnspulse.com/authors/anant-akash-sakthivel/https://cnspulse.com/authors/andreea-chiorean/https://cnspulse.com/authors/andrew-cutler/https://cnspulse.com/authors/andrew-czysz/https://cnspulse.com/authors/andrew-j-cutler/https://cnspulse.com/authors/andrew-krystal/https://cnspulse.com/authors/andrew-nierenberg/https://cnspulse.com/authors/andrew-olagunju/https://cnspulse.com/authors/andrew-van-der-vaart/https://cnspulse.com/authors/andy-ngo/https://cnspulse.com/authors/anissa-abi-dargham/https://cnspulse.com/authors/anita-clayton/https://cnspulse.com/authors/anne-khodarkovskaya/https://cnspulse.com/authors/annsley-martin/https://cnspulse.com/authors/anshu-arora/https://cnspulse.com/authors/anthony-delconte/https://cnspulse.com/authors/antony-loebel/https://cnspulse.com/authors/antony-perzo/https://cnspulse.com/authors/ariyaneh-nikbin/https://cnspulse.com/authors/arjun-athreya/https://cnspulse.com/authors/audrey-shoultz/https://cnspulse.com/authors/bahareh-jabbari/https://cnspulse.com/authors/balwinder-singh/https://cnspulse.com/authors/benedetta-bigio/https://cnspulse.com/authors/benjamin-brody/https://cnspulse.com/authors/benjamin-chandler/https://cnspulse.com/authors/benjamin-george/https://cnspulse.com/authors/benjamin-perry/https://cnspulse.com/authors/brandon-weiss/https://cnspulse.com/authors/brian-j-dawson/https://cnspulse.com/authors/brian-m-sweis/https://cnspulse.com/authors/brian-rothman/https://cnspulse.com/authors/bruce-corser/https://cnspulse.com/authors/bushra-amreen/https://cnspulse.com/authors/caren-strote/https://cnspulse.com/authors/carlos-zarate/https://cnspulse.com/authors/catherine-de-cuba/https://cnspulse.com/authors/charles-conway/https://cnspulse.com/authors/charles-nemeroff/https://cnspulse.com/authors/chris-mikesell/https://cnspulse.com/authors/christen-kutz/https://cnspulse.com/authors/christine-cheah/https://cnspulse.com/authors/christine-zu-eulenburg/https://cnspulse.com/authors/christoph-u-correll/https://cnspulse.com/authors/ciara-halvorson/https://cnspulse.com/authors/clotilde-guidetti/https://cnspulse.com/authors/conclusions-in-this-linked-cohort/https://cnspulse.com/authors/craig-chepke/https://cnspulse.com/authors/craig-thomas/https://cnspulse.com/authors/cristian-daniel-llach-lopez/https://cnspulse.com/authors/dan-iosifescu/https://cnspulse.com/authors/danica-johnson/https://cnspulse.com/authors/daniel-albrecht/https://cnspulse.com/authors/daniel-falk/https://cnspulse.com/authors/daniel-gehrlach/https://cnspulse.com/authors/daniel-jeffries/https://cnspulse.com/authors/daniel-karlin/https://cnspulse.com/authors/daphne-weeks/https://cnspulse.com/authors/david-liebers/https://cnspulse.com/authors/david-pattison/https://cnspulse.com/authors/david-plante/https://cnspulse.com/authors/david-walling/https://cnspulse.com/authors/denise-milovan/https://cnspulse.com/authors/diana-orsini/https://cnspulse.com/authors/dimitris-kiosses/https://cnspulse.com/authors/dost-ongur/https://cnspulse.com/authors/edith-liliana-patarroyo-rodriguez/https://cnspulse.com/authors/ellen-bradley/https://cnspulse.com/authors/elombe-calvert/https://cnspulse.com/authors/elssa-toumeh/https://cnspulse.com/authors/emmanuel-mignot/https://cnspulse.com/authors/eric-konofal/https://cnspulse.com/authors/erica-kaczmarek/https://cnspulse.com/authors/erin-ferries/https://cnspulse.com/authors/erin-tireman/https://cnspulse.com/authors/errol-gould/https://cnspulse.com/authors/fancy-f/https://cnspulse.com/authors/farah-khorassani/https://cnspulse.com/authors/fas-krol/https://cnspulse.com/authors/favour-olaoluwa/https://cnspulse.com/authors/francisco-moreno/https://cnspulse.com/authors/fuad-issa/https://cnspulse.com/authors/gabbay-v/https://cnspulse.com/authors/gabrielle-lovell/https://cnspulse.com/authors/gahan-pandina/https://cnspulse.com/authors/gemma-espejo/https://cnspulse.com/authors/george-mcallister/https://cnspulse.com/authors/george-papakostas/https://cnspulse.com/authors/gerard-sanacora/https://cnspulse.com/authors/gia-han-le/https://cnspulse.com/authors/giuseppe-plazzi/https://cnspulse.com/authors/goodman-dw/https://cnspulse.com/authors/grace-marley/https://cnspulse.com/authors/gregory-dance/https://cnspulse.com/authors/gregory-fonzo/https://cnspulse.com/authors/guy-goodwin/https://cnspulse.com/authors/guy-m-goodwin/https://cnspulse.com/authors/harrison-gillman/https://cnspulse.com/authors/helena-kim/https://cnspulse.com/authors/hemangi-r-panchmatia/https://cnspulse.com/authors/henrique-oliva/https://cnspulse.com/authors/heramb-chadchankar/https://cnspulse.com/authors/hiroe-hu/https://cnspulse.com/authors/hrishikesh-kale/https://cnspulse.com/authors/ian-kratter/https://cnspulse.com/authors/ivan-montoya/https://cnspulse.com/authors/james-appio/https://cnspulse.com/authors/james-chua/https://cnspulse.com/authors/james-murrough/https://cnspulse.com/authors/james-thomas/https://cnspulse.com/authors/jaskaran-singh/https://cnspulse.com/authors/jasmine-modasi/https://cnspulse.com/authors/jasmyn-brown/https://cnspulse.com/authors/jason-harris/https://cnspulse.com/authors/jeff-jin/https://cnspulse.com/authors/jeffrey-h-newcorn/https://cnspulse.com/authors/jeffrey-newcorn/https://cnspulse.com/authors/jeffrey-r-strawn/https://cnspulse.com/authors/jeffrey-strawn/https://cnspulse.com/authors/jenicka-engler/https://cnspulse.com/authors/jennifer-payne/https://cnspulse.com/authors/jennifer-swettenham/https://cnspulse.com/authors/jennifer-warner-schmidt/https://cnspulse.com/authors/jens-wendland/https://cnspulse.com/authors/jessica-hamilton/https://cnspulse.com/authors/jessica-malberg/https://cnspulse.com/authors/jill-harkavy-friedman/https://cnspulse.com/authors/jin-soo-byun/https://cnspulse.com/authors/joel-raskin/https://cnspulse.com/authors/joel-young/https://cnspulse.com/authors/john-kane/https://cnspulse.com/authors/john-torous/https://cnspulse.com/authors/john-williams/https://cnspulse.com/authors/jonathan-alpert/https://cnspulse.com/authors/jonathan-kanen/https://cnspulse.com/authors/jordana-kazdan/https://cnspulse.com/authors/jordy-mehawej/https://cnspulse.com/authors/jorge-almeida/https://cnspulse.com/authors/jose-rubio/https://cnspulse.com/authors/joseph-geraci/https://cnspulse.com/authors/joseph-goldberg/https://cnspulse.com/authors/joshua-jordan/https://cnspulse.com/authors/joshua-rosenblat/https://cnspulse.com/authors/julia-forman/https://cnspulse.com/authors/julie-tripp/https://cnspulse.com/authors/kateryna-maksyutynska/https://cnspulse.com/authors/katharine-liang/https://cnspulse.com/authors/katherine-lim/https://cnspulse.com/authors/kaul-i/https://cnspulse.com/authors/keanna-lee/https://cnspulse.com/authors/keren-bachi/https://cnspulse.com/authors/koen-demyttenaere/https://cnspulse.com/authors/konstantina-psychogyiou/https://cnspulse.com/authors/kosalaram-goteti/https://cnspulse.com/authors/kristina-deligiannidis/https://cnspulse.com/authors/kristine-hawkins/https://cnspulse.com/authors/kwadwo-owusu-boaitey/https://cnspulse.com/authors/lars-arvastson/https://cnspulse.com/authors/laura-borghans/https://cnspulse.com/authors/lauren-eide/https://cnspulse.com/authors/lee-cohen/https://cnspulse.com/authors/lei-zhang/https://cnspulse.com/authors/leslie-citrome/https://cnspulse.com/authors/li-zeng/https://cnspulse.com/authors/lisa-b-dixon/https://cnspulse.com/authors/lorenzo-miller/https://cnspulse.com/authors/lori-davis/https://cnspulse.com/authors/mahavir-agarwal/https://cnspulse.com/authors/manish-jha/https://cnspulse.com/authors/manish-k-jha/https://cnspulse.com/authors/manpreet-kaur-singh/https://cnspulse.com/authors/maria-teresa-ferretti/https://cnspulse.com/authors/marian-banh/https://cnspulse.com/authors/mark-frye/https://cnspulse.com/authors/mark-kalinich/https://cnspulse.com/authors/mark-pollack/https://cnspulse.com/authors/mark-rapaport/https://cnspulse.com/authors/mark-zimmerman/https://cnspulse.com/authors/marlene-freeman/https://cnspulse.com/authors/marshall-b-lucas/https://cnspulse.com/authors/matthew-flathers/https://cnspulse.com/authors/matthew-macaluso/https://cnspulse.com/authors/matthew-rudorfer/https://cnspulse.com/authors/maurice-m-ohayon/https://cnspulse.com/authors/mauricio-tohen/https://cnspulse.com/authors/maurizio-fava/https://cnspulse.com/authors/megan-lean/https://cnspulse.com/authors/michael-de-vivo/https://cnspulse.com/authors/michael-detke/https://cnspulse.com/authors/michael-doane/https://cnspulse.com/authors/michael-e-thase/https://cnspulse.com/authors/michael-p-frost/https://cnspulse.com/authors/michelle-r-lofwall/https://cnspulse.com/authors/milica-barac/https://cnspulse.com/authors/mona-darwish/https://cnspulse.com/authors/morgan-hardy/https://cnspulse.com/authors/moses-njuguna/https://cnspulse.com/authors/nabila-haque/https://cnspulse.com/authors/nadia-lipunova/https://cnspulse.com/authors/nair-j/https://cnspulse.com/authors/namik-kirlic/https://cnspulse.com/authors/nandini-jha/https://cnspulse.com/authors/naomi-gaggi/https://cnspulse.com/authors/nassir-ghaemi/https://cnspulse.com/authors/natalie-mcclain/https://cnspulse.com/authors/natasha-mazinani/https://cnspulse.com/authors/nathaniel-counts/https://cnspulse.com/authors/naveen-deevi/https://cnspulse.com/authors/navin-oorjitham/https://cnspulse.com/authors/nelson-rodrigues/https://cnspulse.com/authors/nicholas-demartinis/https://cnspulse.com/authors/nicholas-murphy/https://cnspulse.com/authors/nicolette-stogios/https://cnspulse.com/authors/nidhi-kulkarni/https://cnspulse.com/authors/niki-sabetfakhri/https://cnspulse.com/authors/nilay-hewitt/https://cnspulse.com/authors/nitin-gogtay/https://cnspulse.com/authors/noah-chisamore/https://cnspulse.com/authors/olaoluwa-okusaga/https://cnspulse.com/authors/orly-lipsitz/https://cnspulse.com/authors/paolo-cassano/https://cnspulse.com/authors/pengxiang-li/https://cnspulse.com/authors/peter-hendricks/https://cnspulse.com/authors/peter-j-weiden/https://cnspulse.com/authors/philip-harvey/https://cnspulse.com/authors/plaiphon-vaidyanuvatti/https://cnspulse.com/authors/powers-a/https://cnspulse.com/authors/r-hamish-mcallister-williams/https://cnspulse.com/authors/rachel-dyme/https://cnspulse.com/authors/raffaele-migliore/https://cnspulse.com/authors/rajasumi-rajalingam/https://cnspulse.com/authors/rajnish-mago/https://cnspulse.com/authors/ramakrishna-nirogi/https://cnspulse.com/authors/rana-jawish/https://cnspulse.com/authors/ranran-french/https://cnspulse.com/authors/rashmi-patel/https://cnspulse.com/authors/reem-elbekai/https://cnspulse.com/authors/renny-abraham/https://cnspulse.com/authors/results-of-465-screened-studies/https://cnspulse.com/authors/retsina-meyer/https://cnspulse.com/authors/richard-shelton/https://cnspulse.com/authors/robert-dougherty/https://cnspulse.com/authors/robert-mccarthy/https://cnspulse.com/authors/robin-geever/https://cnspulse.com/authors/rodrigo-machado-vieira/https://cnspulse.com/authors/roger-mcintyre/https://cnspulse.com/authors/roger-s-mcintyre/https://cnspulse.com/authors/ryan-lanier/https://cnspulse.com/authors/saba-saleem/https://cnspulse.com/authors/sajoy-varghese/https://cnspulse.com/authors/sam-cong/https://cnspulse.com/authors/samuel-slocum/https://cnspulse.com/authors/samuel-wilkinson/https://cnspulse.com/authors/sara-di-luch/https://cnspulse.com/authors/sara-katherine-mourani/https://cnspulse.com/authors/sara-rose-shannon/https://cnspulse.com/authors/sarah-king/https://cnspulse.com/authors/sarah-mcewen/https://cnspulse.com/authors/sarah-small/https://cnspulse.com/authors/sarah-stankowicz/https://cnspulse.com/authors/sarina-mohanty/https://cnspulse.com/authors/saydra-wilson/https://cnspulse.com/authors/scott-aaronson/https://cnspulse.com/authors/scott-vuocolo/https://cnspulse.com/authors/sean-o-sullivan/https://cnspulse.com/authors/session/https://cnspulse.com/authors/shabnam-hossein/https://cnspulse.com/authors/shreya-vasudeva/https://cnspulse.com/authors/simon-ward/https://cnspulse.com/authors/snoben-kuruvila/https://cnspulse.com/authors/songjun-li/https://cnspulse.com/authors/sophie-holmes/https://cnspulse.com/authors/soumya-staton/https://cnspulse.com/authors/stefania-chaikali/https://cnspulse.com/authors/suresh-durgam/https://cnspulse.com/authors/tam-nguyen-cao/https://cnspulse.com/authors/ted-obi/https://cnspulse.com/authors/tiffany-farchione/https://cnspulse.com/authors/tiffany-lago/https://cnspulse.com/authors/todd-gould/https://cnspulse.com/authors/tracy-hicks/https://cnspulse.com/authors/tracy-van/https://cnspulse.com/authors/trisha-suppes/https://cnspulse.com/authors/valentina-mantua/https://cnspulse.com/authors/venkatesh-goura/https://cnspulse.com/authors/vicki-wing/https://cnspulse.com/authors/vilma-gabbay/https://cnspulse.com/authors/virgilio-garza/https://cnspulse.com/authors/wies-aw-j-cuba-a/https://cnspulse.com/authors/willie-earley/https://cnspulse.com/authors/willie-r-earley/https://cnspulse.com/authors/yanina-flossbach/https://cnspulse.com/authors/yaroslav-winter/https://cnspulse.com/authors/ying-yu/https://cnspulse.com/authors/ynhi-thomas/https://cnspulse.com/authors/yoojin-lee/https://cnspulse.com/authors/yu-ping-wang/https://cnspulse.com/authors/yuefeng-huang/https://cnspulse.com/authors/yuki-nishi/https://cnspulse.com/authors/yulin-hswen/https://cnspulse.com/authors/yuya-honda/https://cnspulse.com/authors/yves-dauvilliers/https://cnspulse.com/authors/yvette-sheline/https://cnspulse.com/authors/zachary-zuschlag/https://cnspulse.com/authors/zaki-n/https://cnspulse.com/conferences/https://cnspulse.com/conferences/2026-ascp-annual-meeting/